GlassScriptPhysician profile
Nicholas G Tullo
NPI 1982603239
$8,095.71
in general payments reported to CMS, 2019-2025
33 companies · $827 in 2025
The $827 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,922 · 2020: $85.23 · 2021: $409 · 2022: $566 · 2023: $1,332 · 2024: $954 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,113.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,589.93 | 2019-2025 | Cardiomems, Aveir |
| Novartis Pharmaceuticals Corporation | $905.63 | 2019-2025 | |
| Pfizer INC. | $443.49 | 2019-2025 | |
| Boston Scientific Corporation | $412.87 | 2023-2025 | Watchman Flx, Cds - Mct/Cem Monitoring, Watchman |
| Merck Sharp & Dohme LLC | $377.44 | 2022-2025 | Verquvo |
| Amgen INC. | $342.06 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $249.62 | 2019-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $242.23 | 2023-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.10 | 2023-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $170.25 | 2019-2024 | |
| Philips North America LLC | $143.98 | 2022-2025 | (Ck4) Mcot, Extended Holter |
| Baxter Healthcare | $141.72 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Janssen Pharmaceuticals, INC | $96.36 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $92.21 | 2023-2024 | Edarbi, Edarbi |
| Medtronic, INC. | $74.31 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $67.16 | 2023 | |
| Bridgebio Pharma, INC. | $56.27 | 2025 | Attruby |
| Novo Nordisk INC | $51.54 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $50.61 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $48.09 | 2022-2025 | Onpattro |
| Arbor Pharmaceuticals, INC. | $45.24 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $43.18 | 2021-2024 | Farxiga |
| Amarin Pharma, INC. | $42.33 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $42.06 | 2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $41.45 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $34.03 | 2023 | |
| Impulse Dynamics (USA) INC. | $26.25 | 2024 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $21.87 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.35 | 2023 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $14.86 | 2023 | Arcalyst |
| Cleerly, INC. | $14.79 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Kowa Pharmaceuticals America, INC. | $14.43 | 2022 | |
| Bardy Diagnostics, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Tullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.